The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review

Современная онкология

Liudmila G. Zhukova¹  Elena I. Kovalenko²  M. A. Frolova³  Irina V. Poddubnaya⁴  Joseph Gligorov⁵ 

[1] A.S.Loginov Moscow Clinical Scientific Practical Center of the Department of Health of Moscow;Blokhin National Medical Research Center of Oncology;N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation;Russian Medical Academy of Continuous Professional Education;Sorbonne University;

关键词: breast cancer;    pik3ca mutation;    pi3k inhibitor;    alpelisib;   

DOI  :  10.26442/18151434.2020.4.200568

来源: DOAJ

【 摘 要 】

The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer was held on 16th October 2020. The French and Russian oncology experts shared information and exchanged experience concerning the application of the first PI3K inhibitoralpelisib.

【 授权许可】

Unknown